In vitro activity of dalbavancin and telavancin against staphylococci and streptococci isolated from patients in Canadian hospitals: results of the CANWARD 2007

In vitro activity of dalbavancin and telavancin against staphylococci and streptococci isolated from patients in Canadian hospitals: results of the CANWARD 2007–2009 study

Published:2011-03 Issue:3 Volume:69 Page:342-347
ISSN:0732-8893
Container-title:Diagnostic Microbiology and Infectious Disease
language:en
Short-container-title:Diagnostic Microbiology and Infectious Disease

Author:

Karlowsky James A.,Adam Heather J.,Poutanen Susan M.,Hoban Daryl J.,Zhanel George G.

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference26 articles.

1. Activities of dalbavancin against a worldwide collection of 81,673 Gram-positive bacterial isolates;Biedenbach;Antimicrob. Agents Chemother.,2009

2. Activity of dalbavancin tested against Staphylococcus spp. and beta-hemolytic Streptococcus spp. isolated from 52 geographically diverse medical centers in the United States;Biedenbach;J. Clin. Microbiol.,2007

3. Dalbavancin: a novel antimicrobial;Chen;Int. J. Clinic. Practice.,2007

4. Comparative genomics of Canadian epidemic lineages of methicillin-resistant Staphylococcus aureus;Christianson;J. Clin. Microbiol.,2007

5. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard-seventh edition, M7-A7;Clinical and Laboratory Standards Institute (CLSI),2006

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-life experience with IV dalbavancin in Canada; results from the CLEAR (Canadian LEadership on Antimicrobial Real-life usage) registry;Journal of Global Antimicrobial Resistance;2024-09

2. National surveillance of antimicrobial susceptibilities to ceftaroline, dalbavancin, telavancin, tedizolid, eravacycline, omadacycline, and other comparator antibiotics, and genetic characteristics of bacteremic Staphylococcus aureus isolates in adults: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) program in 2020;International Journal of Antimicrobial Agents;2023-04

3. Dalbavancin Boosts the Ability of Neutrophils to Fight Methicillin-Resistant Staphylococcus aureus;International Journal of Molecular Sciences;2023-01-28

4. Clinical efficacy and safety of novel lipoglycopeptides in the treatment of acute bacterial skin and skin structure infections: a systematic review and meta-analysis of randomized controlled trials;Expert Review of Anti-infective Therapy;2021-10-06

5. The role of dalbavancin in the treatment of acute bacterial skin and skin structure infections (ABSSSIs);Expert Review of Anti-infective Therapy;2020-03-29